Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
MAIA Quote, Financials, Valuation and Earnings
Last price:
$1.69
Seasonality move
:
-9.85%
Day range:
$1.74 - $1.90
52-week range:
$1.40 - $4.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
11.08x
Volume:
1.6M
Avg. volume:
539.9K
1-year change:
-51.37%
Market cap:
$54.8M
Revenue:
--
EPS (TTM):
-$0.79
Earnings Data
Next earnings date for MAIA
Aug 08
2025
Most recent earnings per share
-$0.16
Beat by $0.02
(May 9/2025)
Consensus Estimate
-$0.18
(May 9/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MAIA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.19 | -- |
| 08/08/2025 | Q2 | -- | -- | -- | -$0.25 | -- |
| 05/09/2025 | Q1 | -- | -- | -$0.16 | -$0.18 | $0.02 |
| 03/27/2025 | Q4 | -- | -- | -$0.12 | -$0.35 | $0.23 |
| 11/12/2024 | Q3 | -- | -- | -$0.11 | -$0.47 | $0.36 |
| 08/09/2024 | Q2 | -- | -- | -$0.40 | -$0.42 | $0.02 |
| 05/08/2024 | Q1 | -- | -- | -$0.46 | -$0.39 | -$0.07 |
| 03/22/2024 | Q4 | -- | -- | -$0.41 | -$0.39 | -$0.02 |
| 11/09/2023 | Q3 | -- | -- | -$0.36 | -$0.38 | $0.02 |
| 08/22/2023 | Q2 | -- | -- | -$0.35 | -$0.43 | $0.08 |
| 05/08/2023 | Q1 | -- | -- | -$0.38 | -- | -- |
| 03/24/2023 | Q4 | -- | -- | -$0.36 | -- | -- |
| 11/09/2022 | Q3 | -- | -- | -$0.48 | -- | -- |
| 08/22/2022 | Q2 | -- | -- | -$0.32 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.36 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.27 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.32 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.09 | -- | -- |
MAIA Biotechnology Earnings Questions
-
How Much did MAIA Biotechnology Generate in Revenue Last Quarter?
MAIA Biotechnology reported -- worth of top line sales in its most recent quarter.
-
Did MAIA Biotechnology Beat Earnings Last Quarter?
MAIA Biotechnology announced earnings per share of -$0.16 which represents a beat of analyst forecast a -$0.18 per share.
-
Is MAIA Biotechnology Profitable?
MAIA Biotechnology reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for MAIA Biotechnology EPS Next Year?
MAIA Biotechnology's earnings are forecast to decrease from -$1.05 per share to -$1.61 per share next year representing a decrease of -28.57%.
-
When is MAIA Biotechnology's Earnings Date?
MAIA Biotechnology's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 3.83% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is down 0.31% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 3.77% over the past day.
